MDS Virtual Congress 2020 » Parkinson's Disease: Pathophysiology

A longitudinal study on alpha-synuclein in plasma neuronal exosomes as a biomarker for Parkinson’s disease development and progression

M. Niu, Y. Li, G. Li, L. Zhou, N. Luo, M. Yao, W. Kang, J. Liu (Shanghai, China)

A Parkinson’s disease (PD) case with underlying cerebral small vessel disease (CSVD)

L.X Cao, W. Dong, Y. Li, G. Du, J.H Yin, Q. Yang, Y.Q Zhang, B. Chen, Y. Huang (Beijing, China)

Age-dependent expression of α-synuclein and its modification in non-neurodegenerative intestinal tract

L. Bu, K. Huang, Y. Liang, S. Peng, Y. Chen (Guangzhou, China)

Alpha synuclein BAC transgenic mice as a preclinical model for disease-modifying therapies in Parkinson’s disease

H. Yamakado, S. Okuda, T. Taguchi, M. Ikuno, M. Uemura, N. Uemura, M. Hondo, M. Yanagisawa, R. Takahashi (Kyoto, Japan)

An agent-based model replicates the pathogenic spread of alpha-synuclein in mice

S. Rahayel, B. Mišić, Y.Q Zheng, Z.Q Liu, A. Caputo, K. Luk, A. Dagher (Montreal, QC, Canada)

An objective comparison of forward and backward postural instability in early Parkinson’s disease

C. Lu, S. Amundsen Huffmaster, K. Louie, R. McGovern, C. MacKinnon, S. Cooper, R. Lowe, J. Vitek, R. Abulu (Minneapolis, MN, USA)

Biomarkers for Parkinson´s Disease with Reflex Tears Correlate with Disease Duration

M. Lew, S. Janga, D. Feigenbaum, D. Freire, M. Edman, W. Mack, C. Okamoto, S. Hamm-Alvarez (Los Angeles, CA, USA)

Characterization of striatal dopaminergic neurotransmission in the rat pre-formed fibril models of Parkinson’s disease

I. Del Priore, N. Chambers, M. Coyle, R. Fassler, J. Patterson, C. Kemp, A. Stoll, K. Miller, K. Luk, C. Sortwell, C. Bishop (Binghamton, NY, USA)

Dietary and Plasma Polyunsaturated Fatty Acids in Parkinson’s Disease

D. Yoo, Y. Lim, T. Ahn (Seoul, Republic of Korea)

Difference in distribution between alpha-synuclein oligomers and Lewy bodies in Parkinson’s disease brain

H. Sekiya, H. Kowa, Y. Hashimoto, M. Takata, R. Matsumoto, T. Toda (Kobe, Japan)

Disease progression characterized by motor performance, dopaminergic neurodegeneration and T cell infiltration in the transgenic hm2-α-SYN-39 mouse model of Parkinson´s disease

J. Behnke, L. Rauschenberger, S. Knorr, J. Volkmann, C.W Ip (Wuerzburg, Germany)

Effectiveness of lead position with microelectrode recording based support vector machine for characterizing the sub-cortical-structures via deep brain stimulus in Parkinson`s disease

V. Rama Raju (Hyderabad, India)

Evaluation of Birth Order in Parkinson’s Disease

M. Kuzu kumcu, S. Tezcan Aydemir, Ç. Ulukan, M. Sorgun, M. Akbostancı (Ankara, Turkey)

Identifying biomarkers to predict disease progression in early stage Parkinson’s disease patients

L. Neilson, J. Baird, B. Lobb, H. Vanderjagt, N. Gray, S. O'Connor, J. Quinn (Portland, OR, USA)

Increased epinephrine in the saliva of Parkinson’s disease patients: A preliminary observation

P. Wichit, S. Thanprasertsuk, T. Hopetrungraung, O. Phokaewvarangkul, S. Bongsebandhu-phubhakdi, R. Bhidayasiri (Bangkok, Thailand)

Interaction between genetic variants and serum levels of organochlorine pesticides contributes to Parkinson’s disease

S.Q Xu, X.D Yang, Y.W Qian, Q. Xiao (Shanghai, China)

Long-term effects of air pollution on the risk of Parkinson’s disease

Y.S Hwang, S.Y Jo, Y.J Kim, K.W Park, S.H Lee, S.J Chung (Seoul, Republic of Korea)

Maladaptive motor cortex plasticity off medication in Parkinson’s disease patients with levodopa-induced dyskinesias

M. Dileone, C. Ammann, V. Catanzaro, R. Piredda, M.G Monje, I. Navalpotro-Gómez, A. Bergareche, L. Vela, F. Alonso-Frech, M.J Catalán-Alonso, J.A Molina, N. López-Ariztegui, F. Hernández-Fernández, B. Fernández-Rodríguez, C. Gasca-Salas, J.U Máñez-Miró, R. Martínez-Fernández, A. Sánchez-Ferro, A. Oliviero, J.A Obeso, G. Foffani (Móstoles, Spain)

Mixed pathologies in pancreatic beta-cells from subjects with neurodegenerative diseases and their interaction with prion protein

R. Valenti, I. Martinez, I. Amat, I. Marcilla, G. Marti, L. Armengou, C. Caballero, M.R Luquin (Pamplona, Spain)

Motor onset of Parkinsonʼs disease: Is there a somatotopic pattern?

M. Monje, A. Sánchez-Ferro, L. Vela-Desojo, F. Alonso-Frech, M. Di Leone, J. Pineda-Pardo, G. Foffani, J. Obeso (Móstoles, Madrid, Spain)

Movement Disorders After Bariatric Surgeries – Case Series

G. Fabiani, C.H Camargo, H. Teive (Curitiba, Brazil)

Non-mercaptalbumin as a potential biomarker of oxidative stress in Parkinson’s and PARK2 disease

S. Ueno, T. Hatano, A. Okuzumi, S. Saiki, Y. Oji, A. Mori, T. Koinuma, M. Fujimaki, H. Takeshige-Amano, A. Kondo, N. Yoshikawa, T. Nojiri, M. Kurano, K. Yasukawa, Y. Yatomi, H. Ikeda, N. Hattori (Tokyo, Japan)

Parkinson’s disease and chronic inflammatory demyelinating polyneuropathy with celiac disease: Improvement in neuropathy but not Parkinson’s symptoms after intravenous immunoglobulin and gluten free diet

M. Pullman, T. Brannagan, R. Saunders-Pullman (New York, NY, USA)

Parkinson’s disease and osteocalcin pilot study: Is there a protective role of bone in neurodegeneration?

A.S Nordvig, R.N Alcalay, J.M Berger, K. Marder, G. Karsenty, A. Wang (New York, NY, USA)

Phenotype of Parkinson’s Disease in African Americans Using NIH Toolbox Motor Measures

M. Bailey, G. Stebbins, S. Anderson, D. Hall (Chicago, IL, USA)

Predictive factors of serious falls in Parkinson’s disease

H. Matsumoto, M. Shiraishi, S. Tochimoto, K. Tanaka, K. Uchino, Y. Hasegawa (Kawasaki, Japan)

Premotor compensatory mechanisms in Parkinson’s disease with LRRK2-R1441H mutation

S. Sambin, S. Lavisse, C. Decaix, G. Mangone, F. Cormier, B. Le Toullec, S. Lesage, P. Remy, A. Brice, J.C Corvol (Paris, France)

Pulmonary function in Parkinson’s disease

A. O'Callaghan, W. Gray, S. Bourke, R. Walker (North Shields, United Kingdom)

Relationship between tumor and very slow Parkinson`s disease progression

H. Mori (Kurashiki, Okayama, Japan)

Selective α-synuclein overexpression-induced pathology in noradrenergic neurons: a new mouse model for prodromal Parkinson’s disease?

B. Lee, Y. Chen, G. Ganjam, N. Decher, A. Gundlfinger, W.J Berg, M. Britschgi, O. Oertel (Marburg, Germany)

Sensorimotor inhibition relates to gait dysfunction in people with Parkinson’s disease

D. Martini, G. Harker, R. Morris, J. Nutt, F. Horak (Portland, OR, USA)

Spreading ɑ-synuclein pathology initiated from the sublaterodorsal tegmental nucleus models RBD followed by Parkinsonian phenotypes in mice

Y. Shen, W.B Yu, B. Shen, H. Dong, J. Zhao, Y. Fan, Y.F Yang, Y.M Sun, Y.L Tang, F.T Liu, JJ. Wu, B.G Xiao, H. Yu, J. Koprich, Z.L Huang, J. Wang (Shanghai, China)

The interaction of Parkin and TAF15 for the Drosophila in which neuronal defect was induced

E.J Choi, D.G Lee, CC. Cui, K.Y Kim (Ulsan, Republic of Korea)

The role of the disorders in interaction between visual and oculomotor systems and their MRI correlation in patients with camtocormia in Parkinson’s disease

O. Alenikova, S. Likhachev (Minsk, Belarus)

Using machine learning methods to explore gait features associated with freezing of gait in Parkinson’s Disease

M. Amboni, C. Ricciardi, C. De Santis, G. Ricciardelli, G. Improta, M. Cesarelli, P. Barone (Baronissi (Salerno), Italy)